Clinical Trial Update: ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining a combination of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine for malaria in Pakistan. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria
• Vivax Malaria

Drugs mentioned

• Amodiaquine (Amodiaquine)
• Chloroquine (chloroquine)
• Sulphadoxine-pyrimethamine (Sulphadoxine-pyrimethamine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Falciparum Malaria | Phase 3 | Status: COMPLETED